BCAM
EW icon

Boston Common Asset Management’s Edwards Lifesciences EW Stock Holding History

Boston Common Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
160,814
+4,517
+3% +$378K 0.86% 30
2026
Q1 		$12.5M Buy
156,297
+6,744
+5% +$556K 0.81% 38
2025
Q4 		$12.7M Buy
149,553
+13,878
+10% +$1.14M 0.77% 37
2025
Q3 		$10.6M Sell
135,675
-15,187
-10% -$1.19M 0.3% 119
2025
Q2 		$11.8M Buy
150,862
+15,550
+11% +$1.16M 0.33% 112
2025
Q1 		$9.81M Sell
135,312
-17,220
-11% -$1.23M 0.3% 118
2024
Q4 		$11.3M Sell
152,532
-55,392
-27% -$3.88M 0.33% 112
2024
Q3 		$13.7M Buy
207,924
+7,973
+4% +$579K 0.36% 104
2024
Q2 		$18.5M Sell
199,951
-5,319
-3% -$471K 0.47% 78
2024
Q1 		$19.6M Sell
205,270
-20,836
-9% -$1.75M 0.47% 76
2023
Q4 		$17.2M Sell
226,106
-9,314
-4% -$648K 0.39% 97
2023
Q3 		$16.3M Buy
235,420
+17,928
+8% +$1.44M 0.39% 98
2023
Q2 		$20.5M Buy
217,492
+23,123
+12% +$2.01M 0.44% 86
2023
Q1 		$16.1M Buy
+194,369
New +$15.3M 0.33% 114
2022
Q3 		– Sell
-2,354
Closed -$224K – 259
2022
Q2 		$224K Buy
2,354
+185
+9% +$19.2K 0.01% 251
2022
Q1 		$255K Sell
2,169
-233
-10% -$26.1K 0.01% 246
2021
Q4 		$311K Buy
2,402
+329
+16% +$38.4K 0.01% 233
2021
Q3 		$235K Buy
2,073
+17
+0.8% +$1.94K 0.01% 241
2021
Q2 		$213K Buy
+2,056
New +$194K 0.01% 250

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Boston Common Asset Management's EW Position: Q2 2026 in Review

Boston Common Asset Management increased its Edwards Lifesciences (EW) stake by 2.9% in Q2 2026, buying an estimated $378K and bringing the position to 160,814 shares worth $14.5M. The position accounts for 0.86% of the portfolio, ranked #30.

Boston Common Asset Management first reported a position in EW in Q2 2021 and has held it in 19 quarters since. The position peaked at $20.5M in Q2 2023. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Boston Common Asset Management held 160,814 shares of Edwards Lifesciences worth $14.5M as of Q2 2026.
  • Boston Common Asset Management bought 4,517 Edwards Lifesciences shares in Q2 2026, an estimated $378K.
  • Edwards Lifesciences made up 0.86% of Boston Common Asset Management's portfolio in Q2 2026, its #30 holding.
  • Boston Common Asset Management first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 19 quarters since.
  • Boston Common Asset Management's Edwards Lifesciences position peaked at $20.5M in Q2 2023.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.